| HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
94
|
101 |
| CYP21A2 |
P08686
|
cytochrome P450 family 21 subfamily A member 2
|
|
2.6E-04 |
0.525 |
0.769 |
52
|
70 |
| PSORS1C1 |
Q9UIG5
|
psoriasis susceptibility 1 candidate 1
|
|
2.7E-04 |
0.656 |
0.731 |
26
|
24 |
| TNXB |
P22105
|
tenascin XB
|
|
1.9E-02 |
0.572 |
0.731 |
24
|
26 |
| EHMT2 |
Q96KQ7
|
euchromatic histone lysine methyltransferase 2
|
Epigenetic regulator
|
1.0E-04 |
0.590 |
0.808 |
16
|
9 |
| FRMD4A |
Q9P2Q2
|
FERM domain containing 4A
|
|
1.00 |
0.650 |
0.538 |
15
|
23 |
| MSH5-SAPCD1 |
|
MSH5-SAPCD1 readthrough (NMD candidate)
|
|
|
0.760 |
0.423 |
14
|
10 |
| MSH5 |
O43196
|
mutS homolog 5
|
Nucleic acid binding
|
3.2E-11 |
0.641 |
0.692 |
14
|
10 |
| ZNRD1ASP |
|
zinc ribbon domain containing 1 antisense, pseudogene
|
|
|
0.691 |
0.538 |
12
|
8 |
| PRRC2A |
P48634
|
proline rich coiled-coil 2A
|
Enzyme
|
1.00 |
0.656 |
0.654 |
10
|
11 |
| PCSK5 |
Q92824
|
proprotein convertase subtilisin/kexin type 5
|
Enzyme
|
2.5E-12 |
0.659 |
0.538 |
9
|
16 |
| DDR1 |
Q08345
|
discoidin domain receptor tyrosine kinase 1
|
Kinase
|
4.6E-06 |
0.497 |
0.808 |
9
|
5 |
| EHMT2-AS1 |
|
EHMT2 and SLC44A4 antisense RNA 1
|
|
|
0.780 |
0.462 |
8
|
4 |
| PTK2B |
Q14289
|
protein tyrosine kinase 2 beta
|
Kinase
|
0.94 |
0.448 |
0.808 |
6
|
7 |
| HLA-DOB |
P13765
|
major histocompatibility complex, class II, DO beta
|
Immune response
|
1.9E-06 |
0.705 |
0.500 |
6
|
5 |
| ATF6B |
Q99941
|
activating transcription factor 6 beta
|
|
3.1E-07 |
0.839 |
0.192 |
4
|
3 |
| IL6 |
P05231
|
interleukin 6
|
|
0.32 |
0.248 |
0.962 |
4
|
3 |
| RPS9 |
P46781
|
ribosomal protein S9
|
Nucleic acid binding
|
0.88 |
0.780 |
0.154 |
3
|
10 |
| SAPCD1 |
Q5SSQ6
|
suppressor APC domain containing 1
|
|
1.8E-07 |
0.931 |
0.154 |
1
|
3 |
| KLHL33 |
A6NCF5
|
kelch like family member 33
|
|
1.0E-05 |
1.000 |
0.077 |
1
|
1 |